Inflammation more strongly predicts adverse CV events and death than LDL-C in patients on statin therapy: Lancet Medha Baranwal17 March 2023 11:30 AM ISTUSA: A new meta-analysis shows that inflammation is a stronger predictor of future cardiovascular events and death for patients already on statins...
Immediate revascularisation non-inferior to staged complete revascularisation in ACS and multivessel CAD: BIOVASC Medha Baranwal15 March 2023 10:30 AM ISTNetherlands: A recent study in The Lancet has revealed that immediate complete revascularisation is non-inferior to staged complete revascularization...
Secukinumab effectively reduces symptoms and signs of hidradenitis suppurativa Jacinthlyn Sylvia5 March 2023 8:00 PM ISTSecukinumab, when administered every two weeks, was clinically successful at reducing the symptoms and signs of hidradenitis suppurativa while...
SGLT2 inhibitor empagliflozin could be new treatment option for children with type 2 diabetes: Lancet Dr. Kamal Kant Kohli4 March 2023 11:00 AM ISTUSA: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, findings from a phase 3 clinical trial have...
Oral dose of Sebetralstat improves symptoms in acute hereditary angioedema attacks Dr. Shravani Dali27 Feb 2023 8:00 PM ISTResearchers have found in a phase 2 trial that an oral dose of sebetralstat lead to faster symptom relief in acute hereditary angioedema attacks...
Medical Bulletin 25/February/2023 Isra Zaman25 Feb 2023 2:45 PM ISTHere are the top medical news for the day: Oral empagliflozin provided safe glycemic control in children with type 2 diabetes: Phase 3 trial...
Oral empagliflozin provided safe glycemic control in children with type 2 diabetes: Phase 3 trial findings Isra Zaman25 Feb 2023 9:00 AM ISTResearchers led by pediatric endocrinologists at Joslin Diabetes Center recently completed a phase 3 clinical trial that assessed the efficacy and...
Oral Gefitinib and methotrexate combo has no clinical advantage over methotrexate for tubal ectopic pregnancy Dr.Niharika Harsha B16 Feb 2023 9:45 AM ISTA new study found that combining oral gefitinib with parenteral methotrexate has no clinical advantage over methotrexate alone. The study results were...
Targeted therapy momelotinib significantly improves symptoms and anemia in patients with myelofibrosis Dr. Kamal Kant Kohli9 Feb 2023 9:30 AM ISTPatients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated...
Marburg vaccine shows promising results in first-in-human study Dr. Kamal Kant Kohli1 Feb 2023 10:30 AM ISTA newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a...
Sodium bicarbonate for metabolic acidosis correction may not arrest kidney function decline in transplant patients Jacinthlyn Sylvia1 Feb 2023 9:45 AM ISTTreatment of metabolic acidosis with sodium bicarbonate therapy over a two-year period in adult kidney transplant patients had no impact on the fall...
Levofloxacin-based quadruple therapy not superior to bismuth-based quadruple in second-line H pylori treatment Dr.Niharika Harsha B23 Jan 2023 8:00 PM ISTA new trial found that levofloxacin-based quadruple therapy is not superior to bismuth-based quadruple therapy in the second-line treatment of H...
